[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Insulet Corp (PODD)

Insulet Corp (PODD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,817,992
  • Shares Outstanding, K 69,265
  • Annual Sales, $ 2,708 M
  • Annual Income, $ 247,100 K
  • EBIT $ 507 M
  • EBITDA $ 598 M
  • 60-Month Beta 1.11
  • Price/Sales 4.28
  • Price/Cash Flow 26.09
  • Price/Book 8.77

Options Overview Details

View History
  • Implied Volatility 59.74% (+1.17%)
  • Historical Volatility 41.52%
  • IV Percentile 98%
  • IV Rank 94.65%
  • IV High 61.83% on 04/29/26
  • IV Low 22.92% on 08/22/25
  • Expected Move (DTE 22) 10.71 (6.57%)
  • Put/Call Vol Ratio 0.08
  • Today's Volume 67
  • Volume Avg (30-Day) 271
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 7,773
  • Open Int (30-Day) 6,965
  • Expected Range 152.27 to 173.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 27 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.38
  • Number of Estimates 8
  • High Estimate $1.50
  • Low Estimate $0.97
  • Prior Year $1.17
  • Growth Rate Est. (year over year) +17.95%

Price Performance

See More
Period Period Low Period High Performance
1-Month
152.78 +6.69%
on 07/09/26
172.91 -5.74%
on 07/28/26
+10.74 (+7.06%)
since 06/30/26
3-Month
138.79 +17.44%
on 06/22/26
178.04 -8.45%
on 05/01/26
-9.15 (-5.31%)
since 04/30/26
52-Week
138.79 +17.44%
on 06/22/26
354.88 -54.07%
on 11/20/25
-135.27 (-45.35%)
since 07/30/25

Most Recent Stories

More News
PODD Shareholder Alert: Insulet Corporation Securities Class Action Lawsuit - Investors Should Contact SueWallSt

Insulet's CEO and CFO Named as Individual Defendants Under Section 20(a) for Alleged Cumulative Losses Stemming from Defective Omnipod Manufacturing Controls

PODD : 162.95 (-4.50%)
PODD DEADLINE: Levi & Korsinsky Reminds Insulet Corporation Investors of Upcoming Securities Class Action Deadline

Alert: Claims Focus on Alleged Defective Cannula Manufacturing That Caused Insulin Under-Delivery in Millions of Omnipod Devices

PODD : 162.95 (-4.50%)
PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit

NEW YORK , July 28, 2026 /PRNewswire/ --

PODD : 162.95 (-4.50%)
PODD Class Reminder: Insulet Investors are Reminded of the Upcoming August 31 Deadline in the Filed Securities Fraud Class Action to Recover Losses

A securities fraud class action lawsuit has been filed on behalf of Insulet investors after its stock plummeted over 6% because of misrepresentation about the safety of Insulet's Omnipod products.

PODD : 162.95 (-4.50%)
Insulet Corporation Investor Alert: Contact SBS by August 31, 2026 for Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , July 28, 2026 /PRNewswire/ -- Schall Brown & Schwartz LLP , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Insulet Corporation...

PODD : 162.95 (-4.50%)
Insulet Corporation (PODD) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa. , July 27, 2026 /PRNewswire/ -- The Law Offices of Howard G. Smith  announces that investors with substantial losses have opportunity to lead the securities fraud class action...

PODD : 162.95 (-4.50%)
Insulet Corporation (NASDAQ: PODD) Investors Who Suffered Losses May Be Eligible to Participate in Securities Class Action; Contact Robbins LLP for Information About Recovering Your Losses

Lead Plaintiff Deadline: August 31, 2026

PODD : 162.95 (-4.50%)
Insulet Corporation (PODD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES , July 24, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz  announces that investors with losses related to Insulet Corporation ("Insulet" or the "Company") (NASDAQ:  PODD...

PODD : 162.95 (-4.50%)
PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit

NEW YORK , July 23, 2026 /PRNewswire/ --

PODD : 162.95 (-4.50%)
SueWallSt Reminds Insulet Corporation Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of August 31, 2026 - PODD

Insulet's SEC Filings Touted Quality Assurance Inspections "At Various Steps in the Manufacturing Cycle" While Defective Controls at Its Acton Facility Allegedly Produced 7 Million Flawed Pods

PODD : 162.95 (-4.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System...

See More

Key Turning Points

3rd Resistance Point 179.71
2nd Resistance Point 175.75
1st Resistance Point 173.18
Last Price 162.95
1st Support Level 166.65
2nd Support Level 162.69
3rd Support Level 160.12

See More

52-Week High 354.88
Fibonacci 61.8% 272.33
Fibonacci 50% 246.83
Fibonacci 38.2% 221.34
Last Price 162.95
52-Week Low 138.79

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.